Filing Details
- Accession Number:
- 0000899243-20-000730
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-07 17:15:11
- Reporting Period:
- 2020-01-03
- Accepted Time:
- 2020-01-07 17:15:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1552451 | Myokardia Inc | MYOK | Pharmaceutical Preparations (2834) | 455500552 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1654909 | Jake Bauer | C/O Myokardia, Inc. 333 Allerton Avenue South San Francisco CA 94080 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-01-03 | 10,000 | $1.51 | 59,957 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-01-06 | 2,466 | $68.45 | 57,491 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-01-03 | 10,000 | $0.00 | 10,000 | $1.51 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,326 | 2025-06-03 | No | 4 | M | Direct |
Footnotes
- Shares sold to cover withholding taxes in connection with vesting of Restricted Stock Units reported on Form 4 filed by the Reporting Person on January 3, 2020.
- Represents the weighted average sale price of the shares sold ranging from $68.35 to $68.66 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- 25% of the shares subject to this option vested and became exercisable on June 4, 2016, and the remainder vested and became exercisable in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
